Shankar Siva on radiotherapy for primary renal cell carcinoma

Shankar Siva (Peter MacCallum Cancer Centre, Melbourne, Australia) discusses his Article on 5-year outcomes after stereotactic ablative body radiotherapy for primary renal cell carcinoma.

Read the full article:

5-year outcomes after stereotactic ablative body radiotherapy for primary renal cell carcinoma (thelancet.com/journals/lanonc/article/PIIS1470…)00656-8/fulltext)

Tell us what you thought about this episode (buzzsprout.com/1391338/fan_mail/new)

Continue this conversation on social!

Follow us today at...

thelancet.bsky.social

instagram.com/thelancetgroup

facebook.com/thelancetmedicaljournal

linkedIn.com/company/the-lancet (linkedin.com/company/the-lancet)

youtube.com/thelancettv